AIDS. 2007 Jan 30;21(3):361-3.

Balancing effectiveness and access to HIV treatment in the developing world.

Hill A, Wood E.

Source

Pharmacology Research Laboratories, University of Liverpool, 70 Pembroke Place, Liverpool, UK. microhaart@aol.com

Comment on

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. [AIDS. 2007]
Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, Moeung S, Song S, Balkan S, Ferradini L, et al. AIDS. 2007 Jan 30; 21(3):351-9.

PMID:: 17255743; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Comment

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Providing antiretroviral therapy for HIV infection. [N Engl J Med. 2001]
Providing antiretroviral therapy for HIV infection.
Steinbrook R. N Engl J Med. 2001 Mar 15; 344(11):844-6.
Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world. [J Acquir Immune Defic Syndr. 2...]
Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world.
Vijayaraghavan A, Efrusy MB, Mazonson PD, Ebrahim O, Sanne IM, Santas CC. J Acquir Immune Defic Syndr. 2007 Sep 1; 46(1):91-100.
Review Inequalities in health: access to treatment for HIV/AIDS. [Ann Ist Super Sanita. 2007]
Review Inequalities in health: access to treatment for HIV/AIDS.
Giuliano M, Vella S. Ann Ist Super Sanita. 2007; 43(4):313-6.
HIV prevention and treatment in Africa. [AIDS Patient Care STDS. 2000]
HIV prevention and treatment in Africa.
Laurence J. AIDS Patient Care STDS. 2000 Aug; 14(8):399-400.
Review Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries. [Expert Opin Investig Drugs. 2002]
Review Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries.
Kaufmann GR, Smith D, Bucher HC, Phanuphak P, Sendi PP, Mbidde EK, Cooper DA, Battegay M. Expert Opin Investig Drugs. 2002 Sep; 11(9):1303-13.

See reviews... See all...

Cited by 1 PubMed Central article

Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia. [J Acquir Immune Defic Syndr. 2...]
Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia.
Chi BH, Mwango A, Giganti MJ, Sikazwe I, Moyo C, Schuttner L, Mulenga LB, Bolton-Moore C, Chintu NT, Sheneberger R, et al. J Acquir Immune Defic Syndr. 2011 Dec 15; 58(5):475-81.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Balancing effectiveness and access to HIV treatment in the developing world.
Balancing effectiveness and access to HIV treatment in the developing world.
AIDS. 2007 Jan 30 ;21(3):361-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: